Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 3, Issue 3, Pages (May 2017)

Similar presentations


Presentation on theme: "Volume 3, Issue 3, Pages (May 2017)"— Presentation transcript:

1 Volume 3, Issue 3, Pages 215-218 (May 2017)
Acrodermatitis of Hallopeau and erosive oral mucositis successfully treated with secukinumab  Jennifer A. Baron, MD  JAAD Case Reports  Volume 3, Issue 3, Pages (May 2017) DOI: /j.jdcr Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Affected fingers before treatment with secukinumab. Patient reported severe, disabling pain. JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 Affected fingers before treatment with secukinumab. Patient reported severe, disabling pain. JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

4 Fig 3 Labial and gingival mucosa before treatment with secukinumab, showing erosions. Patient reported pain and significant difficulty speaking and eating. JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

5 Fig 4 Erosive circinate glossitis with loss of lingual papillae.
JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

6 Fig 5 Labial and gingival mucosa after 1 month of secukinumab treatment initiation (five subcutaneous injections of 300 mg at intervals of 0, 1, 2, 3, and 4 weeks). JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

7 Fig 6 Appearance of tongue after 1 month of secukinumab treatment initiation. JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

8 Fig 7 Affected fingers five days after initial dose of secukinumab (300 mg injected subcutaneously). JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

9 Fig 8 Affected fingers after one month of secukinumab treatment initiation. JAAD Case Reports 2017 3, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Volume 3, Issue 3, Pages (May 2017)"

Similar presentations


Ads by Google